In Phase C, individuals will get ABBV-744 and oral navitoclax. In Section D, individuals will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment until illness progression or maybe the contributors are unable to tolerate the study drugs. Ubiquitin-similar proteins that control The soundness of vital Tremendous enhancer-mediated proteins have also https://vont000hsd3.life-wiki.com/user